ABSTRACT: Bone regeneration is challenging in sites where the blood supply has been compromised by radiation. We examined the potential of a growth factor (VEGF) delivery system to enhance angiogenesis and bone formation in irradiated calvarial defects. VEGF-releasing polymers significantly increased blood vessel density and vascular perfusion in irradiated defects and increased bone formation relative to control conditions.
INTRODUCTION

I
T IS ESTIMATED that survivors of cancer make up 3.5% of the U.S. population, and of this number, about one half are treated with radiation therapy alone or with a combination of other therapies. (1, 2) Although radiation is a wellaccepted therapeutic modality for carcinomas, there are unfortunately many patients that do not have sustainable regional control of the disease. This frequently results in the need for these individuals to undergo resective surgery to remove the remaining affected tissue, but in most instances, includes the removal of adjacent healthy tissue as well. Even if radiation treatment and resective surgery are successful in eradicating all damaged cells and diseased tissues, the affected area is often left functionally compromised.
Radiation treatment induces vascular damage and leads to reduced perfusion of healthy tissue. This, in turn, severely compromises the process of new blood vessel formation (angiogenesis) and the ability of vessels to deliver oxygen and nutrients to normal tissues. The compromised nature of the irradiated healthy tissue inhibits its capacity to heal and regenerate, often resulting in fibrosis and scarring. (3) In the treatment of head and neck cancers, craniofacial bone defects secondary to resective surgery and radiation therapy are particularly debilitating, not only physiologically but also psychologically. In addition, a small subset of irradiated patients require resection of bone because of osteoradionecrosis, which is often a secondary complication of radiation therapy. The "gold standard" for bone replacement in head and neck reconstruction of irradiated sites is the use of vascularized autologous grafts. (4) Although current methods of reconstruction are frequently successful, there still exist multiple limitations to this therapy. These limitations include donor site morbidity, 5-10% failure rates, several additional hours of surgical time, and great difficulties in precisely restoring the complex 3D structure of various osseous defects. (4) (5) (6) Tissue engineering approaches to reconstructing bone defects in the head and neck region are appealing because of the limitations of current therapy. A number of different strategies aimed at treating osseous defects include bone tissue grafting, cell harvesting and transplantation, gene therapy, and protein delivery. (7) (8) (9) (10) (11) (12) (13) Here we report an approach to enhance blood vessel formation and function, as well as bone regeneration, in a rat model system of irradiated osseous defects compromised in their vasculature. Similar irradiation studies have been used to evaluate bone healing in irradiated calvarial defects in rats, and all have shown that irradiation significantly impairs the regenerative capacity of bone in these defects. (13) (14) (15) (16) The approach used in our study uses a macroporous PLGA (copolymer of D,Llactide and glycolide) scaffold (pore sizes ranging from 250 to 425 m) that readily allows for cell invasion and growth when implanted in vivo. (17) When using these scaffolds as growth factor delivery systems, vascular endothelial growth factor (VEGF) can be incorporated and released in a sustained manner for several weeks, with the released VEGF remaining bioactive and capable of inducing significant angiogenesis. (18, 19) The hypothesis underlying this study is that delivery of VEGF from PLGA scaffolds can sufficiently enhance angiogenesis to enable bone regeneration in osseous defects compromised by radiation therapy.
MATERIALS AND METHODS
Animal irradiation
Fisher rats weighing between 175 and 200 g were used for this study. For rats in the irradiation treatment group, a single 12-Gy dose from a cobalt source ( 60 Co) was delivered to D max at a source-to-skin distance of 80 cm in an 11.47-minute exposure. Radiation was delivered exclusively to the future surgical site. The pharynx and the rest of the body were shielded by a combination of beam collimation and Cerrobend blocks. (20) Rats were anesthetized with ketamine (50 mg/g) and xylazine (5 mg/g) during the radiation treatment, and the radiation dose was given 2 weeks before the surgical procedure. Potential side effects from the radiation were monitored afterward, specifically examining for weight loss, wound healing problems, tissue necrosis, alopecia, ocular problems, and unusual behavior. Animal procedures were approved by the University committee on the use and care of animals at the University of Michigan.
Polymer matrix fabrication with incorporated VEGF
PLGA (85:15 molar ratio; i.v. ‫ס‬ 1.4, Resomer 858; Henley Chemicals, Montvale, NJ, USA) was used in a gasfoaming process (21) 
Calvarial defect model
Treatment of experimental animals was in accordance with the University of Michigan animal care guidelines, and all NIH animal handling procedures were observed. Rats were anesthetized by intraperitoneal injection of anesthetics (80 mg/kg ketamine and 10 mg/kg xylazine). A midlongitudinal incision was made on the dorsal surface of the cranium, and care was taken to ensure that the periosteum was completely cleared from the surface of the cranium by scraping. A trephine bur was used to create two circular 3.5-mm-diameter defects in the rat cranium, one on each side of the parietal suture. The full thickness of the cranial bone was removed, and scaffolds were immediately placed in the defects. The incision was closed with a continuous suture.
Laser Doppler analysis
One, 2, and 6 weeks after implantation of the scaffolds, a laser Doppler blood flow meter (Laser Doppler Perfusion Imager System [LDPI]; Lisca, North Brunswick, NJ, USA) was used to measure blood perfusion in the osseous defects. Perfusion was measured as the ratio of blood flow of VEGF scaffolds to blood flow of PLGA scaffolds. Animals were sedated during this procedure with 2.1% isoflurane at an oxygen flow rate of 2.0 liters/minute. The calvaria of the rats were placed at a fixed reference point 5 cm from the scanner, and the LDPI uses a 12-mW helium-neon laser beam that sequentially scans a 12 × 12-cm surface area of interest to measure blood flow. As the scanning is performed, moving blood cells shift the frequency of incident light according to the Doppler principle. The photodiode collects the backscattered light, and the original light intensity variations are transformed into voltage variations in the range of 0-10 V. A perfusion output value of 0 V was calibrated as 0% perfusion, whereas 10 V was calibrated as 100%. On termination of scanning, a color-coded image representing blood flow distribution displays on a monitor. The perfusion signal was subdivided into six different intervals, each displayed as a separate color. Low or no per-fusion was displayed as dark blue, whereas the highest perfusion interval was displayed as red.
Histological staining
After 2, 6, and 12 weeks, animals were killed with carbon dioxide, and the implants embedded in the surrounding native bone were retrieved. The implants were fixed for 24 h at 4°C in 10% zinc-buffered formalin, and after fixation, implants were analyzed using CT analysis as described later. Implants were subsequently decalcified through a 5-day incubation in 10% EDTA and paraffin embedded (Histology Core Facility, University of Michigan School of Dentistry). Embedded matrices were cut into serial sections (5 m thick) and placed on glass slides for histological staining and analysis. Tissue sections were either stained with Gill's 3 hematoxylin (Sigma) and aqueous eosin Y solution (Sigma) to visualize the overall tissue morphology or immuno-stained with antibodies raised against von Willebrand factor (Factor VIII; DAKO). In performing immunostaining of tissue sections, the slides were first deparaffinized through a descending series of EtOH and rehydrated in H 2 0, after which they were washed for 5 minutes in 3% H 2 O 2 (Sigma) in PBS to quench endogenous peroxidase activity. To improve antigen exposure, the slides were boiled in citrate buffer (Biocare Medical, Walnut Creek, CA, USA) for 2 minutes, at 120°C, in a pressure cooker (Biocare Medical). The sections were incubated for 10 minutes with terminator blocking solution (Biocare Medical) to prevent nonspecific antibody-antigen interactions. A primary antibody for von Willebrand factor was diluted 1:1000 in Da Vinci Green antibody diluent (Biocare Medical), added dropwise onto each section, and allowed to incubate overnight at 4°C. The slides were washed for 10 minutes in PBS, dried of excess PBS, and incubated for 20 minutes with broad-spectrum biotinylated Universal Link (Biocare Medical), which binds to any antibody raised in mice, rats, or rabbits. The slides were washed again with PBS and incubated for 15 minutes with streptavidin-horseradish peroxidase (HRP; Biocare Medical), which has a strong binding affinity for the biotinylated Universal Link. The HRP reaction was completed with the addition of 3,3Ј-diaminobenzidine (DAB; Zymed, South San Francisco, CA, USA) for 30 s. The slides were finally dehydrated, mounted, and coverslipped.
Histological analysis
Tissue sections were visualized and photographed with an E-800 light microscope (Nikon). Samples from each condition were analyzed manually and digitally. Blood vessels present in the implants were analyzed for their total number. Blood vessels were identified, after immunostaining for von Willebrand factor, at ×200 magnification.
Bone histomorphometric analysis of sections stained with H&E was performed to quantitatively determine bone formation. Using an E-800 light microscope, histologic sections from each implant at each time-point were scanned and imported into Adobe Photoshop (Adobe Systems, Mountain View, CA, USA). Bone tissue area for each section was determined by dividing the total number of bone pixels by the total number of scaffold pixels based on color using Image Pro Plus Software. This value was plotted as bone area/tissue area. Identification of bone was based on morphology of eosin-stained tissue and the cells lining (osteoblasts) and within (osteocytes) this tissue.
µCT 3D reconstruction and bone morphometry
Calvaria were scanned by CT (CT MS8X-130; EVS Corp.). The specimens were fitted in a cylindrical sample holder, 15.4 mm in diameter, with the coronal aspect of the calvarial bone in a horizontal position. Specimens were scanned with the scanning direction parallel to the coronal aspect of the calvarial bone. High-resolution scanning, with an in-plane pixel size and slice thickness of 24 m, was performed. To cover the entire thickness of the calvarial bone, the number of slices was set at 400. GEMS MicroView software was used to make a 3D reconstruction from the set of scans. To obtain a 3D image, a threshold value of 1100 was used. Using the 2D CT images of the specimen, the percentage of the defect that was covered with new bone tissue was calculated (% bone coverage). From 3D images of the specimen, the total tissue volume (TV, mm 3 ), bone volume (BV, mm 3 ) and BMD within the defects were measured directly.
Statistical analysis
The statistical analyses were performed with the Instat Software Program. For the neovascularization experiments where blood vessel counting was performed, 12 animals were used. In the laser Doppler and early bone formation analyses, six animals were studied, and one of these animals died after 6 weeks, which accounts for there being five animals studied at the 12-week time-point of bone regeneration. Descriptive analyses were performed initially, followed by the use of Student t-tests or one-way ANOVA, according to the experimental design. All data are plotted as mean ± SE. Statistically significant differences in the histomorphometric analyses were determined using onetailed Student t-tests, and statistical significance was defined as p < 0.05.
RESULTS
Irradiation compromises angiogenesis in osseous defects
To examine the effect of radiation treatment on blood vessel formation in our model system, an isolated area of the calvaria of Fisher rats was administered a therapeutic equivalent 12-Gy dose of radiation from a cobalt source ( 60 Co). The radiation was delivered to D max at a source-toskin distance of 80 cm in an 11.47-minute exposure. Eight weeks after implantation of the scaffolds, one of the animals appeared to have lost a noticeable amount of weight. This animal was monitored more closely and died at 9 weeks. This sample was excluded from the 12-week timepoint, and it could not be determined whether radiation was the ultimate cause of death. There were no observed adverse side effects in any of the other animals after radiation treatment. Two weeks after radiation treatment, two 3.5-mm osseous defects were created in the irradiated site (Fig.  1A) . At the time of surgical creation of the defects, biodegradable polymer scaffolds of PLGA, fabricated by a gasfoaming process, (21) were placed in the defect sites. These scaffolds were also placed in osseous defects created in the calvarium of rats that had not undergone radiation treatment. Two and 6 weeks after implantation of the scaffolds, the scaffolds were retrieved and analyzed for neovascularization, tissue perfusion, and new bone formation within the defect area. Analysis of histological sections 2 weeks after implantation of the scaffolds revealed that fewer blood vessels formed in scaffolds within irradiated defects relative to scaffolds placed in nonirradiated defects (Figs. 1B and 1C) . Quantification of the blood vessel densities at 2 weeks confirmed the results of the histological examination and showed a statistically significant 37% decrease in neovascularization within scaffolds placed in irradiated defects (36.0 vessels/mm 2 ) relative to neovascularization within scaffolds placed in nonirradiated defects (56.9 vessels/mm 2 ; Fig. 1D ). Differences in neovascularization between scaffolds in nonirradiated and irradiated defects were still evident 6 weeks after implantation (Fig. 1D) .
Laser Doppler perfusion analysis
PLGA polymer scaffolds capable of growth factor delivery were fabricated using a variation of the gas-foaming fabrication process. (22) Three micrograms of VEGF was incorporated into these scaffolds (VEGF scaffolds), as previously described, (19) and these scaffolds and PLGA scaffolds were implanted into osseous defects created in rats that had been irradiated 2 weeks preoperatively. As a functional analysis of the effects of VEGF scaffolds on blood vessel formation within the osseous defects, LDPI was performed to assess blood flow to the defect areas. LDPI was conducted 1, 2, and 6 weeks after implantation of PLGA and VEGF scaffolds in nonirradiated and irradiated defects. One week after implantation of PLGA and VEGF scaffolds into osseous defects created in nonirradiated calvaria, LDPI images showed greater perfusion to defects with VEGF scaffolds (Fig. 2A) . This method of imaging and analysis was further characterized in additional experiments (data not shown) and showed reproducibility. It was thus used for all subsequent perfusion analyses. Two weeks after implantation of scaffolds, in both nonirradiated and irradi-
FIG. 2. Laser Doppler perfusion analysis (LDPI). (A)
LDPI image of a nonirradiated calvarium, 1 week after implantation of a PLGA scaffold (right) and a VEGF scaffold (left) into osseous defects (circles). Blood flow to the defect area (circle) is indicated by the differences in color intensity (red most highly perfused > yellow > green > blue > black) throughout the areas of interest. Two weeks after implantation of scaffolds, circles indicate areas in which osseous defects were created in (B) nonirradiated or (C) irradiated defects, followed by placement of either PLGA (right) or VEGF (left) scaffolds. Defects implanted with VEGF scaffolds contained the highest areas of perfusion. (D) Quantification of vascular perfusion within the osseous defects revealed significant increases in perfusion in defects implanted with VEGF scaffolds. Perfusion of VEGF scaffolds was measured as a percentage increase in perfusion relative to perfusion of PLGA scaffolds. Values represent mean ± SE (n ‫ס‬ 6).
FIG. 1. Influence of irradiation on angiogenesis. (A)
CT image of osseous defects created in rat calvarium 2 weeks after radiation treatment (XRT). Two weeks after implantation of scaffolds into defects, qualitative histological analysis of new blood vessel formation in PLGA scaffolds revealed more blood vessels present within defects that were (B) nonirradiated relative to defects that were (C) irradiated. Arrows point to blood vessels (well-defined luminal structure) with positive immunostaining of von Willebrand factor. Magnification of photomicrograph images at ×200. (D) Quantitative analysis of blood vessel densities counted manually (×200) and normalized to tissue area showed that XRT treatment significantly reduced blood vessel formation within the defect areas. Blood vessel densities were measured at 2 and 6 weeks after implantation of scaffolds. Values represent mean ± SE (n ‫ס‬ 12). *p < 0.05. ated osseous defects, LDPI images showed that defect areas that were implanted with VEGF scaffolds were more highly perfused than defect areas implanted with PLGA scaffolds (Figs. 2B and 2C ). Quantitative analysis of blood perfusion revealed that, in nonirradiated defects, there was a 75% (p < 0.05) increase in perfusion of defect areas implanted with VEGF scaffolds relative to those with PLGA scaffolds (Fig. 2D) . Of great interest was the finding that, in irradiated defects, quantitative analysis revealed there was also a statistically significant increase (30%) in perfusion within defect areas implanted with VEGF scaffolds relative to areas implanted with PLGA scaffolds (Fig. 2D) . As a functional analysis, these results showed that the implantation of VEGF scaffolds increased blood flow within not only nonirradiated, but more importantly irradiated, osseous defects.
Effects of VEGF delivery on neovascularization in irradiated sites
Two and 6 weeks after implantation, scaffolds were retrieved, and neovascularization was assessed through histological analysis. Blood vessel densities within VEGF scaffolds (Fig. 3A) were higher compared with blood vessel densities within PLGA scaffolds in these same defects (Fig.  3B) . Quantification of vessel densities revealed that there was a significant increase (>2-fold) in neovascularization within VEGF scaffolds (91.3 vessels/mm 2 at 2 weeks; 76.8 vessels/mm 2 at 6 weeks) relative to PLGA scaffolds (36.0 vessels/mm 2 at 2 weeks; 29.9 vessels/mm 2 at 6 weeks) implanted into irradiated defects (Figs. 3C and 3D) . Furthermore, this analysis also showed that implantation of VEGF scaffolds (91.3 vessels/mm 2 at 2 weeks; 76.8 vessels/mm 2 at 6 weeks) in irradiated defects enhanced blood vessel densities to levels exceeding those of densities within PLGA scaffolds (56.9 vessels/mm 2 at 2 weeks; 38.3 vessels/mm 2 at 6 weeks) implanted into nonirradiated defects (Figs. 3E and  3F ).
Early bone regeneration in irradiated osseous defects
Because the delivery of VEGF increased blood vessel formation and function in the compromised osseous defects, we sought to determine whether this boost in the angiogenic response correlated with wound healing of the defect measured by bone regeneration. The presence of early bone regeneration within these defects was performed through histological analysis 6 weeks after implantation of polymer scaffolds. Gross qualitative histological analysis of whole sections suggested that implantation of VEGF scaffolds resulted in the formation of more bone tissue than implantation of PLGA scaffolds (Figs. 4A and 4B) . Bone tissue had a woven, trabecular appearance with little to no hematopoietic tissue present. High magnification images showed the presence of more organized and mature areas of bone, surrounded by immature regions of bone trabeculae, in VEGF scaffolds relative to PLGA scaffolds (Figs.  4C and 4D) . Quantitative histomorphometric analysis of bone formation revealed a significant (43%) increase in bone formation within VEGF scaffolds (46.2% bone area/ tissue area) relative to bone formed within PLGA scaffolds (31.8% bone area/tissue area; Fig. 4E ).
Mature bone regeneration in osseous defects
To determine the extent of bone formation within VEGF scaffolds in this irradiated model, histological and CT analyses were performed 12 weeks after implantation. Within a 3.5-mm nonirradiated osseous defect, VEGF scaffolds were capable of complete osseous bridging of the de -FIG. 3 . Neovascularization after VEGF delivery in irradiated sites. Photomicrographs of histological sections immunostained for von Willebrand factor to identify blood vessels formed in irradiated sites 2 weeks after implantation of (A) VEGF or (B) PLGA scaffolds. Very few blood vessels were present in the PLGA scaffolds relative to vessels formed in the VEGF scaffolds. Quantification of neovascularization within PLGA and VEGF scaffolds (C) 2 and (D) 6 weeks after radiation treatment (×200 magnification) reveals a statistically significant increase (>2-fold) in vessels formed within defects implanted with VEGF scaffolds. Additional comparisons of treatment groups at (E) 2 and (F) 6 weeks showed that VEGF scaffolds in irradiated defects enhanced blood vessel densities to levels exceeding those of densities within PLGA scaffolds implanted into nonirradiated defects. Values represent mean ± SE (n ‫ס‬ 12). *p < 0.05. fect 12 weeks after implantation (Fig. 5A) , whereas PLGA scaffolds only exhibited partial bone bridging (Fig. 5B) . Within irradiated defects, histological examination of scaffolds revealed greater bone bridging within VEGF scaffolds compared with PLGA scaffolds (Figs. 5C and 5D ). 3D reconstructions of the volume of mineralized tissue formed within the calvarial defects clearly showed that, in both irradiated and nonirradiated conditions, the VEGF scaffolds contained more mineralized tissue than PLGA scaffolds (Fig. 5E ). 2D comparisons of these scaffolds quantitatively showed that VEGF scaffolds (26.3% coverage) resulted in a significantly greater (3-fold) amount of bone healing, as measured by bone coverage, within the irradiated defect compared with bone healing by PLGA scaffolds (7.0%; Fig. 5E ). An additional analysis of bone formation, BMD, was performed, and the results showed that there was also a significant increase (69%) in the BMD of bone tissue formed within the VEGF scaffolds (130.8 mg/cm 3 ), relative to PLGA scaffolds (71.3 mg/cm 3 ), in the irradiated defects (Fig. 5F) 
DISCUSSION
There is a significant need for therapeutic strategies to enhance neovascularization and perfusion in tissues compromised by irradiation. Radiation therapy acts on tumors by destroying rapidly dividing cancer cells; however, it can also damage healthy tissues by killing actively dividing somatic cells. It is well established that radiotherapy can have very serious, and in some cases life-threatening, effects by damaging blood vessels. (23) Radiation can negatively affect vascular function by causing atherosclerosis (24) (25) (26) and can have direct cellular effects on endothelial cells, causing them to separate from the basement membrane of capillaries and undergo apoptosis. (27, 28) The need for treatment modalities that enhance neovascularization in irradiated tissues is especially important for bone regeneration, because bone formation is an angiogenesis-dependent process. (29) Our study showed that by delivering an angiogenic growth factor from a biodegradable polymeric scaffold, blood vessel formation and vascular perfusion can be enhanced in osseous defects where the blood supply has been compromised by radiation treatment. Additionally, this angiogenic response correlates with increased new bone formation in a clinically relevant model system. These findings are particularly interesting in that bone formation was observed in osseous defects without the addition of any known osteoinductive proteins.
Within irradiated defects, there has been a paucity of reports of successful strategies to enhance bone regeneration through the delivery of angiogenic growth factors. Other studies have exploited the use of BMPs in the repair of irradiated osseous defects by using large quantities of these osteoinductive proteins to induce bone formation. Nonetheless, without sufficient vascular support, these approaches are not effective in an irradiated environment. (14, 15) We first examined the efficacy of our irradiated model system and showed that with 12 Gy of radiation delivered 2 weeks preoperatively, blood vessel formation in surgical defects implanted with control scaffolds (PLGA scaffolds) was significantly lower than blood vessel formation in nonirradiated surgical defects implanted with PLGA scaffolds. We have previously reported a system capable of delivering VEGF in a controlled and localized manner (19) and have further shown its ability to enhance angiogenesis when implanted subcutaneously. (18) A key finding from this study is that delivery of VEGF from designed biomaterials can boost the angiogenic response in irradiated osseous defects to levels higher than those seen in nonirradiated defects where no VEGF is delivered.
Although the increase in angiogenesis is an important finding, the net effect of this enhanced angiogenesis is even   FIG. 4 . Early bone regeneration within osseous defects at 6 weeks. Photomicrographs of entire H&E-stained sections of (A) PLGA and (B) VEGF scaffolds retrieved 6 weeks after implantation into irradiated defects (N, native bone around scaffold). High magnification (×200) images of insert areas from A and B of early bone tissue formation within (C) PLGA and (D) VEGF scaffolds suggested the presence of greater bone formation within VEGF scaffolds (B, bone within scaffold). (E) In H&E-stained sections, bone histomorphometric analysis was performed and confirmed that VEGF scaffolds led to a significantly greater amount of bone regeneration than PLGA scaffolds. Bone was measured as percent bone tissue relative to total tissue area within the scaffold sections. Values represent mean ± SE (n ‫ס‬ 6). *p < 0.05. more critical. Perfusion at these sites is of paramount importance because an adequate blood supply will ultimately determine the extent to which regeneration of tissues can be achieved. Another strategy aimed at inducing angiogenesis and improving tissue oxygenation after radiation therapy uses hyperbaric oxygen treatment. (30) (31) (32) (33) However, despite the success of this approach in preclinical and clinical studies, its use has several disadvantages and contrain-
FIG. 5.
Mature bone regeneration at 12 weeks. H&E-stained sections of (A) VEGF and (B) PLGA scaffolds after implantation within nonirradiated defects. VEGF scaffolds resulted in complete bone bridging of the osseous defect, whereas PLGA scaffolds resulted in partial bone bridging (N, native bone around defect; M, mature bone within scaffold). H&E-stained sections of (C) PLGA and (D) VEGF scaffolds in irradiated osseous defects show that there was much greater bone bridging in the VEGF scaffolds relative to PLGA scaffolds. (E) 3D reconstructions of bone volume within scaffolds and quantitative CT analyses of mineralized tissue formation confirmed the presence of a statistically significant increase in bone coverage within VEGF scaffolds compared with PLGA scaffolds in irradiated defects (analyses from nonirradiated defects is included for comparison). (F) CT analysis of BMD of bone formed in PLGA and VEGF scaffolds in nonirradiated and irradiated defects. Values represent mean ± SE (n ‫ס‬ 5). *p < 0.05 relative to PLGA (no XRT); **p < 0.05 relative to PLGA (XRT).
dications. (34) Therefore, the controlled growth factor release system described here may alleviate the need for this expensive and time-consuming therapy. To assess the functionality of neovascularization associated with VEGF delivery, perfusion at the sites of the irradiated defects was measured. The laser Doppler scanning results confirmed that not only was VEGF delivery successful in increasing blood vessel density in the defects but also resulted in regenerated tissue that was significantly more perfused.
Although the vascularity data seem promising from a therapeutic standpoint, it is important to note that the clinical delivery of VEGF in patients undergoing reconstruction can potentially be harmful, particularly if the defect area was originally created by resection of a malignancy. This is especially true because it is well documented that VEGF contributes to the growth of tumors. However, there may be clinical situations that may be amenable to this type of strategy. As an example, previously irradiated regions undergoing craniofacial reconstruction are encountered in three different clinical scenarios: (1) secondary reconstruction after a patient has been tumor-free for many years; (2) reconstructive treatment after osteoradionecrosis, which usually occurs many years after successful cancer therapy has been rendered; and (3) as immediate reconstruction after salvage surgery for patients who have failed radiation therapy as a primary treatment modality. In the first two scenarios, the effects of VEGF on microscopic residual disease in the wound would be of less concern because these patients have generally remained tumor-free for many years and commonly are considered locally cured at the time of reconstruction. In these instances, regional or systemic distribution of the VEGF may be of greater concern because it may have adverse effects on small recurrences of primary tumors, which may be still clinically or radiographically undetectable. In the last scenario, the adverse effects of VEGF on microscopic residual disease would potentially be problematic, and this issue warrants further study in animal models before considering clinical application.
The ultimate therapeutic goal in the treatment of lost and damaged tissues after resective surgical procedures is regeneration of the lost tissue. Based on our histologic findings, there were regions of bone continuity bridging the span of the irradiated calvarial defects after the implantation of VEGF scaffolds. However, a critical finding was observed after quantitative analysis of bone healing. Bone healing, as measured by total bone coverage, after implantation of VEGF scaffolds in irradiated defects was equivalent to bone healing of defects that were nonirradiated. Examining the quality of regenerated bone tissue through measures of BMD revealed that bone tissue within scaffolds was not as highly mineralized as native bone found around the periphery of the original defect, and this may be because of the time frame of our study. However, the BMD of bone formed within VEGF scaffolds was significantly higher than in the small amount of bone formed within PLGA scaffolds. Furthermore, there was no difference in the BMD of bone within VEGF scaffolds implanted into either irradiated or nonirradiated defects.
The ability of VEGF scaffolds to enhance bone formation in irradiated defects can in part be attributed to the enhancement of neovascularization within the scaffolds. It has been well established that the presence of a supportive vasculature is essential in bone formation and regeneration (29, (35) (36) (37) ; however, the possibility cannot be ruled out that VEGF delivery from scaffolds affects more than just the vasculature. VEGF is a potent endothelial cell mitogen previously thought to be devoid of consistent and appreciable mitogenic effects on other cell types. (38) (39) (40) (41) However, there has been recent evidence showing mitogenic and trophic activities of VEGF on a few other non-endothelial cell types, (42) (43) (44) including osteoblasts, (45, 46) bone marrow stromal cells, (47) and osteoclasts. (48, 49) We did not observe any qualitative differences in osteoblast and osteoclast cell numbers between VEGF scaffolds and PLGA scaffolds; however, further studies need to be conducted to elucidate the cellular mechanisms involved in these processes. In addition, VEGF can exhibit synergistic activity with osteoinductive factors and can enhance recruitment of mesenchymal stem cells, prolong cell survival, and augment cartilage and bone formation in bone regenerative sites. (50, 51) Thus, VEGF delivered from biomaterial scaffolds may be acting not only on the vasculature, but also directly on osteoprogenitor cells, osteoblasts, osteoclasts, and conjunctively with osteoinductive factors resident in the osseous defects. Taken together, these findings suggest that growth factor delivery from polymer scaffolds could be an important tool for regenerating and engineering tissues in which the vascular supply has been compromised.
